Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianjun Yu

Showing results (341-350 of 421) with videos related to

Pageof 43
Sort By:
International Journal of Oncology|August 7, 2014
(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumorsGuopei Luo, Zuqiang Liu, Meng Guo, et al.
Annals of Surgical Oncology|March 30, 2019
Surgical Resection for Metastatic Tumors in the Pancreas: A Single-Center Experience and Systematic ReviewQiuyi Huang, Haiyang Zhou, Chen Liu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 10, 2024
BCL6 overexpression in CD4<sup>+</sup> T cells induces Tfh-like transdifferentiation and enhances antitumor efficiency of CAR-T therapy in pancreatic cancerXuan Lin, Zhengjie Dai, Yesiboli Tasiheng, et al.
ACS Nano|April 1, 2026
DNA Repair Enzyme Regulation Strategy for Enhanced Pancreatic Neuroendocrine Tumor Therapy via Targeting siRNA-Lipid NanoparticlesFei Wang, Yan Li, Junfeng Xu, et al.
Ebiomedicine|April 28, 2022
Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancerLongyun Ye, Kaizhou Jin, Zhenyu Liao, et al.
Cell Proliferation|June 28, 2024
Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1Ting Wang, Qiangsheng Hu, Borui Li, et al.
BMC Cancer|November 8, 2024
Distinctive grade based on Ki67 index and immune microenvironment of metastatic pancreatic neuroendocrine tumors responding to capecitabine plus temozolomideHeli Gao, Wuhu Zhang, Zheng Li, et al.
BMC Surgery|May 10, 2022
Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumorsZheng Zhang, Fei Wang, Zheng Li, et al.
Cell Death & Disease|February 25, 2018
TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancerJinfeng Xiang, Qiangsheng Hu, Yi Qin, et al.
Molecular Cancer|August 9, 2014
Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axisWantong Yao, Shunrong Ji, Yi Qin, et al.
Pageof 43

Showing results (341-350 of 421) with videos related to

Sort By:
Pageof 43
International Journal of Oncology|August 7, 2014
(18)F-FDG PET/CT can be used to detect non-functioning pancreatic neuroendocrine tumorsGuopei Luo, Zuqiang Liu, Meng Guo, et al.
Annals of Surgical Oncology|March 30, 2019
Surgical Resection for Metastatic Tumors in the Pancreas: A Single-Center Experience and Systematic ReviewQiuyi Huang, Haiyang Zhou, Chen Liu, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|July 10, 2024
BCL6 overexpression in CD4<sup>+</sup> T cells induces Tfh-like transdifferentiation and enhances antitumor efficiency of CAR-T therapy in pancreatic cancerXuan Lin, Zhengjie Dai, Yesiboli Tasiheng, et al.
ACS Nano|April 1, 2026
DNA Repair Enzyme Regulation Strategy for Enhanced Pancreatic Neuroendocrine Tumor Therapy via Targeting siRNA-Lipid NanoparticlesFei Wang, Yan Li, Junfeng Xu, et al.
Ebiomedicine|April 28, 2022
Hypoxia-reprogrammed regulatory group 2 innate lymphoid cells promote immunosuppression in pancreatic cancerLongyun Ye, Kaizhou Jin, Zhenyu Liao, et al.
Cell Proliferation|June 28, 2024
Transcription factor EB reprograms branched-chain amino acid metabolism and promotes pancreatic cancer progression via transcriptional regulation of BCAT1Ting Wang, Qiangsheng Hu, Borui Li, et al.
BMC Cancer|November 8, 2024
Distinctive grade based on Ki67 index and immune microenvironment of metastatic pancreatic neuroendocrine tumors responding to capecitabine plus temozolomideHeli Gao, Wuhu Zhang, Zheng Li, et al.
BMC Surgery|May 10, 2022
Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumorsZheng Zhang, Fei Wang, Zheng Li, et al.
Cell Death & Disease|February 25, 2018
TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancerJinfeng Xiang, Qiangsheng Hu, Yi Qin, et al.
Molecular Cancer|August 9, 2014
Profilin-1 suppresses tumorigenicity in pancreatic cancer through regulation of the SIRT3-HIF1α axisWantong Yao, Shunrong Ji, Yi Qin, et al.
Pageof 43